You have 9 free searches left this month | for more free features.

mucin-producing cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Biopsy
  • +6 more
  • Los Angeles, California
  • +35 more
Jan 31, 2023

Poorly Differentiated Adenocarcinoma With Signet Ring Cells of

Completed
  • Gallbladder Cancer
  • laparoscopic whole-layer cholecystectomy
  • Ōita, Oita, Japan
    oita Red Cross hospital
Sep 24, 2022

Colon Cancer, Pancreatic Cancer, Cholangiocarcinoma Trial run by the National Cancer Institute (NCI) (MVT-5873, pancreatectomy

Completed
  • Colon Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2022

Metastatic Solid Tumors, Esophageal Cancer, NSCLC Trial in Houston, San Antonio, Toronto (M1231)

Recruiting
  • Metastatic Solid Tumors
  • +2 more
  • Houston, Texas
  • +2 more
Jul 29, 2022

Rectal Cancer Trial in Montpellier, Clermont-Ferrand (Biological collection)

Recruiting
  • Rectal Cancer
  • Biological collection
  • Montpellier, Hérault, France
  • +1 more
Jan 21, 2022

IL-17+ CD8 T Cells in Cancer Patients Trial in Taichung

Completed
  • IL-17+ CD8 T Cells in Cancer Patients
    • Taichung, Taiwan
      China Medical University Hospital
    Jul 27, 2021

    Bacteremia Caused by Gram-Negative Bacteria Trial in Worldwide (Ceftolozane-Tazobactam, Meropenem)

    Withdrawn
    • Bacteremia Caused by Gram-Negative Bacteria
    • Newcastle, New South Wales, Australia
    • +28 more
    May 17, 2022

    Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial in Miami (drug, biological, other)

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • Head and Neck Cancer
    • Miami, Florida
      University of Miami
    Jun 10, 2021

    Gastric Cancer Trial in Beijing (Camrelizumab plus Apatinib and SOX, Camrelizumab plus Apatinib)

    Recruiting
    • Gastric Cancer
    • Camrelizumab plus Apatinib and SOX
    • Camrelizumab plus Apatinib
    • Beijing, China
      Peking University Cancer Hospital
    Oct 23, 2020

    The Status of Immune Checkpoints at Gastrointestinal Cancer

    Completed
    • Gastrointestinal Cancer
    • Flow cytometric analysis
    • Istanbul, Turkey
      Istanbul Training and Reseach Hospital
    Dec 4, 2022

    Pancreatic Cancer Trial in United States (IMMU-107 (hPAM4))

    Completed
    • Pancreatic Cancer
    • IMMU-107 (hPAM4)
    • Newark, Delaware
    • +10 more
    Aug 12, 2021

    Pseudomyxoma Peritonei, Peritoneal Cancer, Mucinous Adenocarcinoma Trial (Bromelain, Acetylcysteine, Interventional radiology

    Not yet recruiting
    • Pseudomyxoma Peritonei
    • +3 more
    • (no location specified)
    Feb 28, 2022

    Breast Cancer Trial in Istanbul (Soluble immune checkpoints)

    Recruiting
    • Breast Cancer
    • Soluble immune checkpoints
    • Istanbul, Turkey
    • +1 more
    Jul 14, 2022

    Tumors, Prostate Cancer, Lung Cancer Trial run by the NCI (ETBX-051; adenoviral brachyury vaccine, ETBX-061; adenoviral Mucin-1

    Completed
    • Neoplasms
    • +4 more
    • ETBX-051; adenoviral brachyury vaccine
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 25, 2020

    Colorectal Cancer Trial (Energy drink)

    Not yet recruiting
    • Colorectal Cancer
    • Energy drink
    • (no location specified)
    Nov 17, 2023

    Mucin Levels in Dry Eye and Normal Populations

    Completed
    • Dry Eye
      • Andover, Massachusetts
        Andover Eye Associates
      Jun 15, 2023

      Pre-Eclampsia Trial (real time PCR)

      Not yet recruiting
      • Pre-Eclampsia
      • real time PCR
      • (no location specified)
      Mar 22, 2022

      IMaC - Immune Pathways in Oesophagogastric Cancer

      Not yet recruiting
      • Oesophagogastric Cancer
      • No intervention sample collection only
      • Guildford, United Kingdom
      • +2 more
      Oct 4, 2023

      Dry Eye Trial in Shenyang (Intense pulsed light, Diquafosol tetrasodium)

      Not yet recruiting
      • Dry Eye
      • Intense pulsed light
      • Diquafosol tetrasodium
      • Shenyang, Liaoning, China
        He Eye Hospital
      Jan 19, 2023

      Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients Trial in Dhaka (lidocaine transdermal patch)

      Recruiting
      • Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients
      • lidocaine transdermal patch
      • Dhaka, Bangladesh
        Bangabandhu Sheikh Mujib Medical University
      May 22, 2023

      Bronchial Inflammation, Small Airways Disfunction and Mucous

      Not yet recruiting
      • Asthma; Eosinophilic
      • Dupilumab
      • (no location specified)
      Mar 15, 2023

      Microbial Colonization, Enzyme Overdose Trial (Eating apples)

      Not yet recruiting
      • Microbial Colonization
      • Enzyme Overdose
      • Eating apples
      • (no location specified)
      Feb 17, 2023

      Solid Tumor, Adult Trial in Beijing (Vaccine)

      Not yet recruiting
      • Solid Tumor, Adult
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Aug 3, 2023

      Ocular Surface of Visual Display Users With and Without Dry Eye

      Completed
      • Dry Eye Disease
      • no intervention
      • Beijing, China
        Peking University Third Hospital
      Nov 20, 2022

      Adenocarcinoma of the Uterine Cervix and HPV

      Not yet recruiting
      • Adenocarcinoma of the Uterine Cervix
      • Conization and/or Hysterectomy
      • (no location specified)
      May 23, 2022